Skip to main content
Glama

Open Contracting

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

TDQS

A4.9/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint, openWorldHint, idempotentHint, and destructiveHint=false. The description adds substantial behavioral context: it cascades through multiple lookup endpoints, degrades gracefully if GLEIF/OpenFIGI are unavailable, explicitly lists unresolved identifiers under 'unresolved' rather than omitting them, and asserts nothing when a name matches multiple instruments (returning figi_candidates). It also explains that it resolves non-equity instruments like bonds, which is a non-obvious behavior. This goes well beyond the annotation hints.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long but dense. It front-loads the usage directive ('Use FIRST whenever you have a name but need an ID') and then organizes information by supported types. While it is a wall of text, every sentence carries operational value—examples, edge cases, degradation behavior, and input format warnings. It could be slightly trimmed (e.g., the CID citation URL might be less critical), but it is structured logically and earns its length.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Despite no output schema, the description covers return behavior comprehensively: what identifiers are returned (CIK, ticker, LEI, FIGI), how ambiguous names are handled (figi_candidates), how unresolved identifiers are presented (under 'unresolved'), and graceful degradation if upstream sources fail. It also addresses non-US issuers and non-equity securities. For a tool with two types and multiple internal sources, the description leaves no significant gap an agent would need to call it correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so the baseline is 3. The description significantly enhances parameter understanding: it explains that for company input you can pass ticker, CIK, ISIN, or name, and specifically warns about bonds (pass the issuer exactly as printed, avoid trailing security-class words). It also clarifies the drug type accepts brand or generic names. This is crucial operational guidance that prevents common errors and goes beyond the schema's basic field descriptions.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description states a specific verb ('resolve') and a clear resource (user-spoken names to canonical identifiers). It provides concrete query examples ('What's the ticker for...', 'find the CIK for...') and explicitly frames the tool as the go-to for name-to-ID conversion. It distinguishes itself from sibling tools implicitly by covering multiple identifier types in one call, and the purpose is unambiguous.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly says 'Use FIRST whenever you have a name but need an ID,' which is a direct when-to-use directive. It also provides guidance on input formats (e.g., passing exactly the issuer name for bonds, not the full noun phrase) and explains what to expect for ambiguous matches (returns figi_candidates rather than asserting). It clarifies that it replaces 2-3 manual lookups, reinforcing its role versus other tools.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Open Contracting toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.7/5.0
Disambiguation2/5

Several tool clusters overlap heavily: ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded, deep_research, discover_tools, and suggest_questions all serve query/discovery purposes; polymarket_edges, polymarket_arbitrage, polymarket_edge_tracker, polymarket_fill_risk, and bet_research all target prediction-market opportunity detection. ask_pipeworx_beta is explicitly identical to ask_pipeworx right now, making the distinction essentially invisible without deep description parsing.

Naming Consistency3/5

Names mix domain prefixes (oc_*, polymarket_*, pipeworx_*), action verbs (validate_claim, resolve_entity, generate_llms_txt), and plain nouns (entity_profile, recent_alerts, recent_changes). Most are readable snake_case, but there is no uniform verb_noun or domain-first convention, so the set feels stylistically fragmented rather than patterned.

Tool Count2/5

35 tools is a heavy surface for a server ostensibly named 'Open Contracting' — only 4 of the 35 tools actually relate to open contracting data. The rest sprawl across general data lookup, prediction markets, memory, subscriptions, npm scanning, and AI visibility, making the tool count feel bloated and unfocused relative to the stated purpose.

Completeness2/5

For the open-contracting domain implied by the server name, the surface is incomplete: there is coverage metadata, search, recent releases, and process history, but no direct retrieval of a single release by ID and no broader OCDS exploration tools. As a general data/Pipeworx toolkit the coverage is wide, but the severe mismatch between the server name and the actual tool set creates a significant gap between expectation and capability.

Resources